Smith-Lemli-Opitz syndrome is an inherited monogenic disorder in which mutations to the 7-dehydrocholesterol (7-DHC) reductase (Dhcr7 ) gene lead to deficits in cholesterol synthesis. As a result, many patients suffer from gross physiological and neurological deficits. The purpose of this study was to identify a potential abnormal behavioral phenotype in a compound mutant mouse model for Smith-Lemli-Opitz disease (Dhcr7 3 -5/T93M ) to further validate the model and to provide potential targets for future therapeutic interventions. We also sought to identify some of the underlying changes in brain function that may be responsible for behavioral differences among groups. The Dhcr7 compound mutant mice were smaller than their single mutant littermates. Both single and compound heterozygous mice made fewer ultrasonic vocalizations when separated from the dam, which may suggest a communication deficit in these animals. Striking increases of the highly oxidizable 7-DHC were observed in the compound mutant mice. 7-Dehydrocholesterol is the precursor to cholesterol and builds up because of decreased function of the mutated Dhcr7 enzyme. Additionally, several differences were noted in the serotonergic system including increased expression of the serotonin transporter and increased uptake of serotonin by isolated synaptosomes. We propose that changes to the oxidative environment during development can have a significant impact on the development of serotonergic function and that this contributes to behavioral differences observed in the mutant mice.
Smith-Lemli-Opitz syndrome (SLOS) is a monogenic neurodevelopmental disorder. It results from inherited mutations in both copies of the gene coding for 7-dehydrocholesterol (7-DHC) reductase (Dhcr7), the last enzyme in the cholesterol biosynthesis pathway. Cholesterol is an essential component of cell membranes and neurotransmitter transporter regulation, and is highly enriched in the brain. A clinically significant portion of SLOS patients (50-75%) present with autism spectrum disorder behaviors (Nowaczyk & Irons 2012; Sikora et al. 2006) . At present, there is no cure for SLOS, and only moderately successful treatments for partial alleviation of some symptoms (Svoboda et al. 2012) .
In addition to cholesterol depletion, Dhcr7 dysfunction leads to accumulation of its highly reactive precursor 7-DHC. 7-Dehydrocholesterol is the most oxidizable lipid identified to date, and its autoxidation leads to formation of over a dozen distinct oxysterols both in vitro and in vivo (Porter 2000) . Many of these are measurable both in human SLOS fibroblasts, and in the brain and other organs of Dhcr7 mutant mice, while only barely present or not measurable in control cells and animals (Xu et al. 2009 (Xu et al. , 2011 . Oxysterols also decrease viability of cultured neurons and neuronal cell lines indicating their potential role in neural damage Xu et al. 2012) .
The molecular pathophysiology underlying behavioral changes in SLOS and autism spectrum disorder is poorly understood, but there is evidence for the involvement of the serotonergic (5-hydroxytryptamine or serotonin, 5-HT) system in SLOS and autism in general (Posey et al. 2006; Scott & Deneris 2005; Waage-Baudet et al. 2003) . The most consistent neurochemical finding in autism spectrum disorder is increased levels of blood platelet 5-HT (Cook & Leventhal 1996) . We propose that at least part of the abnormal behavioral phenotype observed in SLOS patients may be linked to aberrant development of the serotonergic system because of high levels of oxidative damage during a critical window of development.
A compound heterozygous mouse line carrying two different mutations derived from human SLOS cases [Dhcr7 Δ3-5/T93M (Correa-Cerro et al. 2006) ] models many of the major physiological facets of the disease. These include decreased embryonic and postnatal survival rates, enlarged ventricles and two to three toe syndactyly. The Dhcr7 Δ3-5/T93M mice also have elevated tissue 7-DHC levels in cortex and midbrain although some improvement is seen with age (Correa-Cerro et al. 2006; Marcos et al. 2007; Meljon et al. 2013) . The compound mutant model is an important advance in the SLOS research field as it more accurately represents the clinical population, in which patients typically carry two different mutations, compared with earlier models that carried a single Dhcr7 mutation. Far more than 100 different mutations of DHCR7 have been reported, but DHCR7 T93M is one of the most common human missense mutations across multiple populations and usually presents with a reasonably mild SLOS phenotype (Correa-Cerro & Porter 2005) . Nevertheless, these mice have not yet been fully behaviorally phenotyped as juveniles or adults, data that will be critical in supporting the genotype-phenotype relationship.
We sought to identify abnormal behavioral outcomes in juvenile Dhcr7 Δ3-5/T93M mice that may relate to the autism phenotype observed in patients. We therefore focused on ultrasonic communication in pups separated from the dam. We hypothesized that mutant mice would also show differences in serotonergic function as a result of oxidative damage by oxysterols during critical windows of serotonergic development.
Materials and methods

Mice and breeding
The Dhcr7 Δ3-5/WT and Dhcr7 T93M/T93M mice were originally obtained from Dr Forbes D Porter, NICHD. These mice were backcrossed for >10 generations onto a C57Bl/6J background. Homozygous Dhcr7 T93M/T93M mice are viable and carry a point mutation in the T89 codon in mouse Dhcr7 (single amino acid substitution -methionine for threonine) which is homologous to the T93 codon in the human gene (Correa-Cerro et al. 2006) . The second SLOS model carries a null disruption of Dhcr7 incorporating a deletion of coding exons 3, 4 and 5 ( Δ3-5 ) (Wassif et al. 2001) . Homozygous Dhcr7 Δ3-5/Δ3-5 mice do not survive past birth. Initial breedings to obtain experimental parents were from Dhcr7 Δ3-5/+ × Dhcr7 Δ3-5/+ and Dhcr7 T93M/WT × Dhcr7 T93M/WT allowing for generation of wild-type (WT) mice for breeding. The Dhcr7 WT WT controls are bred from WT littermates of the mutant breeders in order to match the background strain. Experimental SLOS mutant mice are bred by crossing Dhcr7 T93M/T93M with Dhcr7 Δ3-5/WT . Litters are obtained from both Dhcr7 T93M/T93M and Dhcr7 Δ3-5/WT dams to control for potential influence from maternal genotype. Offspring are either Dhcr7 T93M/Δ3-5 (compound heterozygous) or Dhcr7 T93M/WT (single heterozygous). Female mice were single-housed or in pairs following mating, until 48 h prior to expected delivery at which point they were single-housed. Pups remained with the dam until postnatal days (P) 21-22 at which point they were weaned and/or euthanized. All animal housing and testing procedures were approved by the Vanderbilt Institutional Animal Care and Use Committee. Both male and female offspring were tested on all measures. Behavioral testing took place during the light phase.
Experimental diets
Diets were designed using Research Diets, Inc. (New Brunswick, NJ, USA) for an earlier study (Harrison et al. 2009a) and have previously been used with an alternative SLOS mouse model (Korade et al. 2013a) . The antioxidant (AOX) diet (D04101103) contains -tocopherol 400 IU/kg diet with vitamin C at 1 g/kg diet. The control diet (AIN-76A) contains 50 IU vitamin E provided in the standard vitamin mix and no vitamin C. In contrast, standard chow used in all other experiments (Lab Rodent Diet, 5001) contains no vitamin E or C.
Survival
Following timed matings, pregnant dams were single-housed in clean cages beginning 2-3 days before expected delivery. Dams were checked daily, by 0900 h, for signs of delivery. On P0-P2, pups were counted and any dead pups (whole or partial) were removed and stored at −20 ∘ C for genotyping. Survival rates are calculated from seven litters from WT mice and six litters from mutant mice.
Weight
To avoid unnecessary handling, pups were weighed on a gram scale only on days when behavioral tasks were scheduled (P7, P10 and P21). Samples from N = 62 WT, N = 59 Dhcr7 T95M/WT and N = 14 Dhcr7 Δ3-5/T95M mice were tested at P7.
Ultrasonic vocalizations
Ultrasonic vocalizations (USVs) were measured at P7 [when vocalizations peak in C57Bl/6 mice (Scattoni et al. 2009)] . Mice were briefly removed from the dam and placed individually in an insulated, sound-attenuating chamber. The USVs were measured for 10 min using an ultrasonic microphone and Avisoft software Version 4.2 (Avisoft Bioacoustics, Glienicke, Germany). Samples from N = 56 WT, N = 48 Dhcr7 T95M/WT and N = 13 Dhcr7 Δ3-5/T95M mice were tested at P7.
Nest building
Five grams of bedding material (∼2 nestlets, Ancare, Bellmore, NY, USA) was added to the cages on the day of birth. Nest quality was scored on a scale of 1-5, 24 and 48 h later (based on Deacon 2006).
Pup retrieval
At P10, pups were removed from the home cage and placed on a warming pad. Three pups were placed in different corners of the home cage that did not contain the nest. The dam was returned to the cage and timed for latency to pick up each pup, and to return each to the nest. Samples from N = 8 WT litters and N = 5 Dhcr7 mutant litters were tested.
Activity
At P21, pups were tested in automated locomotor activity chambers for 30 min (30 × 30 × 16 cm 3 ; Med Associates, Inc., Fairfax, VT, USA). Lighting within the box is fixed at 32 lx, with fans in each chamber providing a low level of standardizing background noise (∼75 dB SPL (sound pressure level)). Samples from N = 102 WT, N = 52 Dhcr7 T95M/WT and N = 13 Dhcr7 Δ3-5/T95M mice were tested.
Neuromuscular strength
Following activity measurements, mice were tested for grip strength on the inverted screen task (two trials; Harrison et al. 2008) . The equipment was adapted for younger mice by affixing a smaller wire mesh to the screens.
Sterols
Cholesterol, desmosterol, lanosterol and 7-DHC samples were obtained using Folch and/or specific lipid extraction protocols and run using High performance liquid chromatography mass spectrometry (HPLC-MS), with standards synthesized at Vanderbilt (Korade et al. 2013b; Liu et al. 2014) . Samples from N = 8 WT, N = 7 Dhcr7 T95M/WT and N = 5 Dhcr7 Δ3-5/T95M mice were tested.
Oxidative stress
Lipid peroxidation products were measured as malondialdehyde [thiobarbituric acid (Sigma Aldrich St. Louis, MO, USA) reactive substances] as published (Harrison et al. 2009b) . Samples from N = 24 WT, N = 20 Dhcr7 T95M/WT and N = 6 Dhcr7 Δ3-5/T95M mice were tested.
Eicosanoids
F 2 -Isoprostanes and F 4 -neuroprostanes were measured by the Vanderbilt Eicosanoid Core according to published methods (Milne et al. 2007) . Samples from N = 11 WT, N = 17 Dhcr7 T95M/WT and N = 4 Dhcr7 Δ3-5/T95M mice were tested.
5-HT, dopamine and metabolites
Monoamines were measured in cortex using HPLC through the Vanderbilt Neurochemistry Core as described (Ye et al. 2015) . Samples from N = 15 WT, N = 19 Dhcr7 T95M/WT and N = 6 Dhcr7 Δ3-5/T95M mice were tested.
SERT expression
Expression of serotonin transporter (SERT) in midbrain was measured using Western blot with anti-5HTT antibody (Frontier Institute Co., Hokkaido, Japan, diluted 1:2000) with secondary antibody anti-guinea pig IgG (A7289, 1:5000, Sigma Aldrich) as described (Ye et al. 2015) . Expression of SERT was normalized to expression of -actin (D35E4, 1:400, Santa Cruz Biotechnology, Dallas, TX, USA) with anti-goat IgG (A5420, 1:5000, Sigma Aldrich) as a secondary antibody. Protein samples from N = 6 WT, N = 6 Dhcr7 T95M/WT and N = 5 Dhcr7 Δ3-5/T95M mice were tested.
5-HT uptake in synaptosomes
Radiolabeled [ 3 H]-5-HT (50 μM) uptake into isolated synaptosomes (50 μg) from freshly dissected midbrain tissue was performed for 10 min at 37 ∘ C using a Brandel Cell Harvester (Gaithersburg, MD, USA), as previously described (Ye et al. 2015) . Results were calculated as moles/mg protein/min × 10 −16 with normalization to control animals within each of three separate experiments. Samples from N = 5 WT, N = 6 Dhcr7 T95M/WT and N = 1 Dhcr7 Δ3-5/T95M mice were tested.
Statistical analyses
Whole litters were tested on behavioral measures because mice were not genotyped until sacrifice at P21. Data were analyzed using SPSS 22.0 (SPSS, IBM, Armonk, NY, USA) for Mac. Each variable was checked for normality and skew. Normally distributed data were analyzed using univariate analysis of variance (ANOVA) with Fisher's LSD-corrected post hoc comparisons following a significant omnibus ANOVA. For data that violated assumptions of normality Kruskal-Wallis, non-parametric analyses were used with individual Mann-Whitney analyses on pairs of data to establish differences among groups. P-value was corrected by number of comparisons (i.e. = 0.05/3). Where comparisons were made between two groups only, t-tests were conducted (two-tailed). Data were first analyzed with sex as a separate variable. No differences according to sex were detected so data were collapsed by genotype unless otherwise stated. For biochemical measures, samples were selected pseudorandomly from different litters according to sex and genotype.
Results and discussion
Lower survival and body weight in mutant mice
Mendelian statistics suggest that litters should be comprised of 50% of each mutant genotype (Dhcr7
and Dhcr7 T93M/Δ3-5 ). However, SLOS mutant mice, and in particular Dhcr7 T93M/Δ3-5 mice, were significantly less likely to survive past P2 both for primiparous and experienced dams ( 2 = 29.3, P < 0.001; 2 = 7.75, P < 0.01, respectively; Fig. 1a ). The Dhcr7 T93M/Δ3-5 mice were also smaller than their Dhcr7 T93M/WT littermates at P7 (t(63) = 2.80, P < 0.01; Fig. 1b ) and P21 (Mann-Whitney U = 65.6, P < 0.01; Fig. 1c) . A similar smaller size and decrease from expected numbers of compound mutant pups was observed by Correa-Cerro et al. (2006) and was attributed to maternal genotype (Dhcr7 T93M/T93M ). We observed the same lower number of compound heterozygous pups from both Dhcr7 T93M/T93M and Dhcr7 Δ3-5 /WT dams. Direct comparisons were only made between Dhcr7 T93M/WT and Dhcr7 T93M/Δ3-5 littermates and not from WT mice to avoid the confounding factor of litter size. Sex differences were not observed at either age (P > 0.6), so data were combined for both sexes.
Dhcr7 mutant mice make fewer and shorter calls when separated from the dam Clear and valid behavioral and neuropathological targets help in understanding the etiology of disease and in testing potential therapies. The USV is an early form of social communication that occurs between pups and dams, particularly in response to separation from the nest or physiological stress. We chose USV in juvenile mice as a task that has both construct and face validity for autism spectrum disorders (Crawley 2000) and which is affected in other mouse models of autism spectrum disorders (Ey et al. 2011) . At P7, Dhcr7 T93M/Δ3-5 and Dhcr7 T93M/WT mice made significantly fewer USVs than WT following separation from the dam (Kruskal-Wallis 2 = 10.62, P < 0.01; individual Mann-Whitney U follow-up analyses showed both genotypes were significantly lower than WT at P < 0.016 -corrected for multiple (3) comparisons; Fig. 1d ). The mean duration of calls was also shorter in the mutant mice, although this was only significant in Dhcr7 T93M/WT pups (F 2,125 = 4.62, P < 0.05; Fig. 1e ). Mouse USVs have been clearly shown to be an effective means to elicit response from the dam, and to be altered in multiple mouse models of neurodevelopmental disorders (Scattoni et al. 2009 ). Alternative causes for decreased USVs in rodents include changes in temperature, olfactory and tactile information and pain (Blumberg & Sokoloff 2001; Hofer 1996) that are part of the maternal-infant interaction, but are more a result of physiological than psychological modulation. Although all experimental conditions were identical for each of the genotypes, it is possible that the smaller Dhcr7 T93M/WT pups were differentially affected by the different temperature in the test chamber compared with their nest, which could reflect an additional reason for decreased survival in these pups.
Juvenile mice were tested at P21 for activity and measures of neuromuscular strength. Total distance traveled in 20 min did not differ at this age (F 2,161 = 2.33, P = 0.10; Fig. 1f) , and all mice spent a similar amount of time in the center versus the edge of the chamber during the first 5 min of testing (Kruskal-Wallis 2 = 2.42, P = 0.30; Fig. 1g ). Given the smaller size of the compound mutant pups, we had expected to see poorer performance on a test of neuromuscular strength. Performance on the inverted screen task did not vary according to genotypes (P > 0.75); however, performance was poor in all genotypes at this age, with an overall mean latency to fall of 17.77 seconds (±SEM = 1.42).
Maternal behaviors did not differ according to Dhcr7 genotype
It was not possible to breed WT and mutant littermates, and thus Dhcr7 mutant mice, but not WTs, were bred from dams that also carried at least one mutated copy of the Dhcr7 gene (either Dhcr7 Δ3-5/WT or Dhcr7 T93M/T93M ). We therefore included some measures of maternal behavior to establish that USV differences among pups were not because of differences in maternal treatment, or in physical differences among the genotypes, particularly given the smaller size of the mutant mice. Nest building did not differ according to dam genotype during the critical first 2 days post-birth during which death rates were highest in mutant mice. All mice scored a minimum of 4 out of 5, indicating that >90% of nesting material had been used to build a clearly identifiable nest, although the nest may not have had all walls greater than the mouse's height (Deacon 2006 , data not shown). We initiated pup retrieval testing to provide a measure of whether dams may be less responsive to calls from mutant genotypes. If that was the case, then lower call numbers could be a learned behavior through decreased reinforcement rather than resulting from a developmental difference. We observed no differences in latency to retrieve the first pup (t(11) = 0.64, P = 0.54; Fig. 1h ) or to return all three pups to the nest (t(11) = 1.79, P = 0.10) at P10 according to genotype of the dam (WT, or Dhcr7 T93M/T93M and Dhcr7 Δ3-5/WT ; Fig. 1i ). Pup genotypes were not established until sacrifice at P21-22 and pups were selected from the litter at random for retrieval task. Nevertheless, 40% of the first pups retrieved by mutant dams were Dhcr7 T93M/Δ3-5 , indicating that it is unlikely that dams were less responsive to calls from these pups.
Overall, these findings suggest that USV differences in the pups are not because of differences in maternal behaviors or gross activity of physical differences in the compound heterozygous mice. We therefore sought to establish neurological differences that may have contributed to the effects observed.
Sterol and oxidative stress levels differed according to genotype Cholesterol
A subpopulation of autism cases also have reduced cholesterol levels (Tierney et al. 2006) , which may be undiagnosed cases of SLOS, or at least share a common pathophysiological pathway in addition to sharing the disruption of serotonergic function. There was a trend toward decreased cholesterol in the cortex of Dhcr7 T93M/Δ3-5 mice (F 2,17 = 2.66, P = 0.09; Fig. 2a ). Some correction in this model has been noted (Marcos et al. 2007) . It is therefore likely that the cholesterol deficit in Dhcr7 T93M/Δ3-5 and potentially Dhcr7 T93M/WT mice would have been significant at P7 when USV was undertaken, although this was not measured explicitly. Lanosterol, which is an early precursor for cholesterol synthesis, did not differ among groups (P = 0.15, data not shown). An additional role for the Dhcr7 enzyme is conversion of 7-dehydrodesmosterol to desmosterol. We showed a significant decrease in desmosterol in Dhcr7 T93M/Δ3-5 mice (F 2,17 = 17.78, P = 0.001; Fig. 2b ), indicating that the mutations did indeed impact enzymatic function.
7-Dehydrocholesterol
The 7-DHC was used as an indirect measure of Dhcr7 enzyme activity, with higher levels indicating lower activity of the enzyme. The levels of 7-DHC were extremely low in all WT samples. It increased significantly in Dhcr7 T93M/WT mice (Kruskal-Wallis 2 = 16.71, P < 0.001; Fig. 2c ) and even more so in Dhcr7 T93M/Δ3-5 mice. Given the highly oxidizable nature of both 7-DHC and the oxysterols that are its breakdown products, we hypothesized that this accumulation may be the primary driver cause of neurological abnormalities, rather than cholesterol deficiency alone.
Oxidative stress
There is a strong oxidative damage component in SLOS, and AOX therapies are already in use in some populations. To show that the oxidative imbalance in SLOS is specific to, or at least highly dependent on 7-DHC, we assessed other markers of lipid peroxidation. Malondialdehyde (MDA) was significantly elevated in Dhcr7 T93M/WT mice (F (2, 48) = 4.53, P = 0.05; Fig. 2d ) compared with WT (P < 0.01) and also with Dhcr7 T93M/Δ3-5 mice (P < 0.05) indicating altered oxidative profile in those mice. MDA derives from the oxidation of arachidonic acid and thus the lower MDA levels in Dhcr7 T93M/Δ3-5 mice more likely reflect a balance between increased oxidative stress and less of the starting material rather than a protected state in compound mutant mice compared with littermates. We sought to confirm this pattern of effects among the groups by measuring isoprostanes and neuroprostanes. Isoprostanes are also derived from arachidonic acid, but offer a more specific and stable marker of oxidative damage. Neuroprostanes are derived from docosahexaenoic acid. Neither measure was significantly different among groups (F 2 -isoprostanes Kruskal-Wallis 2 = 2.04, P = 0.36; F 4 -neuroprostanes, Kruskal-Wallis 2 = 0.29, P = 0.87; Fig. 2e,f) . Both arachidonic acid and docosahexaenoic acid were decreased in brain of an alternate knockout mouse model for SLOS, although decreases were only significant for docosahexaenoic acid (Dhcr7 tm1Gst/J , knockout) (Korade et al. 2013b) . In those mice there were no differences in isoprostanes, but a significant elevation of neuroprostanes was observed. Our data support changes in the oxidative stress profile of this mouse model. However, future work should focus on the SLOS-specific oxidative damage mechanism relating to oxidized 7-DHC and downstream products (oxysterols).
Dhcr7 mutant mice exhibit changes in serotonin levels and uptake in midbrain 5-HT and biogenic amines
The drug classes most frequently prescribed for behavioral management in autism spectrum disorders and SLOS include serotonergic modifiers such as SSRIs (selective serotonin reuptake inhibitors). Although beneficial in many cases of autism spectrum disorders, SLOS patients may respond differently to such drugs if connectivity or transporter expression varies in this population. It thus becomes critical to identify the specific deficit(s) in 5-HT brain system in order to tailor treatments to ameliorate behavioral problems.
At P21, 5-HT was increased in the cortex of Dhcr7 T93M/Δ3-5 (Kruskal-Wallis 2 = 6.24, P < 0.05; Fig. 3a ) compared with WT mice. Detected levels of 5-hydroxyindoleacetic acid (5-HIAA), its breakdown product, did not differ among groups, which was reflected in a lower 5-HIAA/5-HT ratio in these mice (Kruskal-Wallis 2 = 1.70, P = 0.43; Kruskal-Wallis 2 = 6.64, P < 0.05, respectively; Fig. 3b,c) . No differences among groups were found in dopamine, nor any of its breakdown products (3,4-Dihydroxyphenylacetic acid (DOPAC), Homovanillic acid (HVA) and 3-Methoxytyramine (3-MT)), nor in the DOPAC/DA (Dopamine) ratio (all P > 0.15).
If the increased serotonin was related to altered uptake in these animals, and if this finding translates to humans, it could be a critical factor in establishing how a patient may respond to SSRIs and similar drugs. The activity of SERT was increased following 1 month of treatment with cholesterol-lowering simvastatin in hypercholesterolemic patients (Vevera et al. 2005) . The expression of SERT in midbrain was elevated in mutant mice, although this was only significant in Dhcr7 T93M/Δ3-5 mice (F 2,14 = 3.65, P < 0.05) and not Dhcr7 T93M/WT mice (P = 0.053; Fig. 3d ). To assess whether this related to functional differences in 5-HT uptake, we prepared synaptosomes from freshly dissected midbrain and cortex. There was increased uptake of radiolabeled 5-HT in synaptosomes from midbrain of Dhcr7 T93M/WT mice compared with WT animals (t(9) = 2.91, P < 0.05; Fig. 3e ). The same difference was not observed in cortical preparations (t(9) = 2.0, P = 0.08; Fig. 3f ). To minimize inter-experimental differences, data are provided as uptake relative to WT control. Data range for midbrain was 2.99 (WT) to 7.31 (Dhcr7 T93M/Δ3-5 ) moles/mg protein/min × 10 −16 , and for cortex was 3.86 (WT) to 7.75 (Dhcr7 T93M/Δ3-5 ) moles/mg protein/min × 10 −16 . Statistical analyses were not performed on synaptosome extracts from Dhcr7 T93M/Δ3-5 mice because only a single animal was born in the three litters that were available for this assay. Nevertheless, uptake in midbrain synaptosomes of the Dhcr7 T93M/Δ3-5 mouse studied was even greater than that observed in the Dhcr7 T93M/WT mice.
AOX supplementation to pregnant females supports normal weight in offspring but does not alter sterol profile in brain
Vitamin C is critical for recycling of vitamin E to prevent -tocopherol radicals contributing to pro-oxidant rather than AOX reactions. Although not an essential supplement for mice which can synthesize their own vitamin C in liver (unlike humans), during pregnancy vitamin C synthesis increases in mice to match needs of fetuses (Corpe et al. 2010) . Its addition to the diet helps to protect against additional strain on the maternal environment by oxidative stress because of her own or the fetal genotypes. We have previously shown that these diets significantly increase vitamin E ( -tocopherol) in both brain and liver at P0 in heterozygous Dhcr7 tm1Gst/J mutant mice (Korade et al. 2013a) , and more importantly, decrease 7-DHC-derived oxysterols in brain. -Tocopherol inhibited accumulation of 3β,5 -dihydroxycholest-7-en-6-one (DHCEO), an oxysterol derived from 7-DHC in cultured fibroblasts carrying SLOS mutations (Korade et al. 2013a) . The AOX supplementation also modified expression of a number of genes involved in lipid biosynthesis in these cells. We therefore sought to understand whether an AOX diet enriched with -tocopherol and ascorbic acid (Harrison et al. 2009a; Korade et al. 2013a) provided to the pregnant dam could be sufficient to modify some of the abnormalities observed in the Dhcr7 T93M/WT and Dhcr7 T93M/Δ3-5 mice. Multiparous dams were used to improve odds of survival among Dhcr7 T93M/Δ3-5 mice. Two out of 14 pups died in AOX-supplemented dams (14.2%, from two litters), which was not different from control-supplemented mice (20.9% from nine litters; P > 0.05). We noted a gain in weight in AOX-supplemented Dhcr7 T93M/Δ3-5 mice compared with non-supplemented Dhcr7 T93M/Δ3-5 mice (t(13) = 3.05, P < 0.01; Fig. 4a ), which was not observed in Dhcr7 T93M/WT (t(48) = 1.82, P = 0.075) or WT mice (t(68) = 0.32, P = 0.75, data not shown). The diet did not alter the highly elevated levels of 7-DHC in the brain in Dhcr7 T93M/Δ3-5 mice (Fig. 4b) .
Conclusions
Our data suggest that it may be important to shift the focus of SLOS research to recognize specific neurological changes to the oxidative environment in these patients and the potential effect on serotonergic function. We propose that decreasing the oxidative damage that occurs during critical windows of development could impact serotonergic system development and thus have a direct impact on neural health and behavior. These relationships, along with safety of supplement-type interventions during pregnancy, must also be studied in human populations. If found to be effective, then early interventions to prevent damage could minimize deficits and optimize quality of life for patients and families.
